Bian J, Fung J, Lee LK, Tam WY, Wong LC, Wong CK,. Genetic Characterization of Influenza A Viruses Circulating in Hong Kong, China, 2023: The first influenza epidemic after the lifting of 2.5 years of COVID-19 non-pharmaceutical interventions. Emerg Microbes Infect. 2025 Jun 16:2521850
During the COVID-19 pandemic, stringent public health measures led to historically low influenza activity in Hong Kong. However, after these interventions were relaxed in 2023, Influenza A viruses (IAV), including A(H1N1)pdm09 and A(H3N2), rapidly resurfaced. In this study, 1,046 clinical cases collected throughout 2023 underwent comprehensive genomic analysis using Oxford Nanopore Technologies (ONT). Phylogenetic analyses of the assembled genome segments were conducted alongside several global public sequences for comparison. The dataset is comprised of 593 A(H1N1)pdm09 sequences, predominantly of hemagglutinin (HA) subclade 5a.2a and neuraminidase (NA) subclade C.5.3, and 453 A(H3N2) sequences classified mainly as HA subclade 2a.3a.1 and NA subclade B.4.3. Phylogenetic comparisons revealed close genetic relationships between the studied viruses and 30 A(H1N1)pdm09 and 27 A(H3N2) sequences published in other regions during the same time. Additionally, identified amino acid substitutions may affect antigenicity and viral fitness. These findings underscore Hong Kong´s high post-COVID-19 influenza diversity and the need for ongoing molecular surveillance to monitor emerging viral variants.
See Also:
Latest articles in those days:
- Extended influenza seasons in Australia and New Zealand in 2025 due to the emergence of influenza A(H3N2) subclade K viruses 6 hours ago
- Dynamic ensemble deep learning with multi-source data for robust influenza forecasting in Yangzhou 6 hours ago
- Structural and immunological characterization of the H3 influenza hemagglutinin during antigenic drift 6 hours ago
- Novel Highly Pathogenic Avian Influenza A(H5N1) Virus, Argentina, 2025 9 hours ago
- Avian influenza overview September - November 2025 1 days ago
[Go Top] [Close Window]


